Bull, Bear & Beyond – Basilea Pharmaceutica: executive interview

Bull, Bear & Beyond – Basilea Pharmaceutica: executive interview

Basilea Pharmaceutica — 2 videos in collection

More on this equity

Basilea Pharmaceutica, a Switzerland-based commercial-stage biotech company, specialises in developing innovative treatments for infectious diseases. In this video, CEO David Veitch highlights the urgent need for new therapies to combat severe bacterial and fungal infections. He also discusses the company’s global commercial strategy and the compelling investment opportunity it presents. With a market capitalisation of CHF540m, Basilea is positioned at the forefront of addressing critical healthcare challenges.

Listen on your preferred podcast player below:

About Bull, Bear & Beyond: Each episode features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets and 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.


You may also be interested in these:

Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.